Dilan Athauda

机构：The Francis Crick Institute, National Hospital for Neurology and Neurosurgery, University College London · ORCID：0000-0001-8594-2483

发表论文 73 篇 · 总被引 4238 次 · h-index 27

代表论文

• Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity (2022 · Nature Neuroscience · 被引 265)
• Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial (2025 · The Lancet · 被引 149)
• The Impact of Type 2 Diabetes in Parkinson's Disease (2022 · Movement Disorders · 被引 131)
• Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons (2022 · npj Parkinson s Disease · 被引 67)
• Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease (2023 · Brain · 被引 34)
• Combining biomarkers for prognostic modelling of Parkinson’s disease (2022 · Journal of Neurology Neurosurgery & Psychiatry · 被引 33)